C-Z5VJOncolife Therapeutics
stem cell biology, molecular therapies, cancer
modulating
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-Z5VJ
C-Z5VJC-Z5VJstem cell biology, molecular therapies, cancer
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Oncolife Therapeutics stem cell biology, molecular therapies, cancer
Oncolife Therapeutics focuses on understanding human stem cell biology to uncover molecular therapies for cancer. The company states that aging compromises stem cell activity and that it aims to identify molecular mechanisms driving oncogenic change. Its stated goal is to intervene when stem cell activity becomes poorly regulated in cancer to increase healthspan and lifespan.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Oncolife Therapeutics — Far from goals · Bottom quartile. Derived deterministically from 1 extracted project(s). Most-advanced status: undisclosed. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic